Document is current
Any future updates will be listed below
-
Authors
Gerusz, Vincent https://orcid.org/0009-0005-4583-8733
Regenass, Pierre
Rousseau, Quentin
Moraine, Victor
Dao, Justine
Lavé, Xavier https://orcid.org/0009-0008-9084-2696
Das, Shampa
Hue Perron, Josée https://orcid.org/0009-0004-2289-2545
Fajas Descamps, Laurence
Bravo, Juan
Dieppois, Guennaëlle
Kaplan, Nachum
Lefebre, Matthew
Altomari, Deanna
Romanov, Vladimir
Finn, Terry
Daram, Pierre
Bernardini, Francesca
Gross, Michaël
Lysek, Robert
Adam, Aurélien
Pohin, Danig
Maio, Maurizio
Tatsis, Vasileios
Sunose, Mihiro
Ronin, Céline https://orcid.org/0000-0002-0930-5316
Ciesielski, Fabrice
Ahlstrand, Josefine
Jacobsson, Susanne
Unemo, Magnus https://orcid.org/0000-0003-1710-2081
Cameron, David R. https://orcid.org/0000-0003-3700-5625
- License Information
-
More Information
Article History
Received: 19 December 2023
Accepted: 21 August 2025
First Online: 18 September 2025
Competing interests
: V.G., V.T., M.S., J.B., and T.F. are listed as inventors on the patent application WO2020099341 “Antibiotic compounds, methods of manufacturing the same, pharmaceutical compositions containing the same and uses thereof” which covers compound 2, Debio 1453 and Debio 1453P listed in this manuscript. V.G., P.R., Q.R., V.M., M.G., R.L., A.A., D.P., M.M., were each employees of Debiopharm Research and Manufacturing SA. J.D., X.L., J.H.P., L.F.D., J.B., G.D., T.F., P.D., F.B., and D.R.C. were each employees of Debiopharm International SA. S.D. and N.K. were paid consultants of Debiopharm International SA. The remaining authors declare no competing interests.
